BIOTECH Logo

BIOTECH

A biotechnology group offering preclinical services, intein development, and licensing.

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera

Description

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-06-25 08:20
Net Asset Value(s)
English 4.0 KB
2020-06-24 09:14
Net Asset Value(s)
English 4.0 KB
2020-06-23 09:56
Net Asset Value(s)
English 4.0 KB
2020-06-22 15:42
Net Asset Value(s)
English 4.0 KB
2020-06-19 10:18
Net Asset Value(s)
English 4.0 KB
2020-06-18 15:29
Net Asset Value(s)
English 4.0 KB
2020-06-17 10:44
Net Asset Value(s)
English 4.0 KB
2020-06-16 10:55
Net Asset Value(s)
English 4.0 KB
2020-06-15 09:42
Net Asset Value(s)
English 4.0 KB
2020-06-12 08:27
Net Asset Value(s)
English 4.1 KB
2020-06-11 08:10
Net Asset Value(s)
English 4.1 KB
2020-06-10 08:12
Net Asset Value(s)
English 4.1 KB
2020-06-09 08:27
Net Asset Value(s)
English 4.1 KB
2020-06-08 09:40
Net Asset Value(s)
English 4.1 KB
2020-06-05 16:10
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOTECH

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Transgene Logo
Develops cancer immunotherapies using vaccines and oncolytic viruses.
France
TNG
TRANS GENIC GROUP INC. Logo
Biotech firm offering drug discovery support and investment/consulting services.
Japan
2342
TriSalus Life Sciences, Inc. Logo
Oncology company integrating drug delivery with immunotherapy to treat solid tumors.
United States of America
TLSI
TScan Therapeutics, Inc. Logo
A clinical-stage biotech developing TCR-engineered T cell therapies for cancer.
United States of America
TCRX
Tsubota Laboratory Incorporated Logo
R&D company developing treatments for ophthalmology and CNS disorders.
Japan
4890
TuHURA Biosciences, Inc./NV Logo
A Phase 3 immuno-oncology company developing therapies for immunotherapy resistance.
United States of America
HURA
Tyra Biosciences, Inc. Logo
Clinical-stage biotech developing precision medicines targeting FGFR biology.
United States of America
TYRA
UCAR Logo
A nonprofit consortium of universities advancing atmospheric and Earth system sciences.
France
ALUCR
Ulisse Biomed Logo
Develops an integrated platform for distributed and connected diagnostic solutions.
Italy
UBM
UNIVERSAL DISPLAY CORP \PA\ Logo
Researches, develops, and supplies OLED technologies and materials for displays.
United States of America
OLED

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.